Special Videos

Beyond the Distinguished Lecturer Series, Summer Institute on Neurodevelopmental Disorders, and Minds Behind the MIND lecture series, the MIND Institute hosts many "special event" lectures on a range of topics.  This page provides access to all of these lectures.  As with all of our lecture videos these can be found in the "Videos By Topic" section of the website as well.

Videos and audio are now exclusively available in the UC Davis MIND Institute Media Player. Adobe Flash and Javascript are needed to play back all media on the MIND Institute website. Chances are that Flash and Javascript are already a part of your browser as they are installed on almost all computers connected to the Internet. However, if you are having difficulty playing any media on this site, Adobe Flash can be downloaded from Adobe's website and instructions for enabling Javascript in your browser are available here. Get more information and help on using the new MIND Institute Media Player.

These webcasts are intended for personal, non-commercial, educational use.  Please do not re-broadcast, re-encode, or otherwise distribute these webcasts without prior written permission from the UC Davis MIND Institute.

Exercising Down's Synapses: The Impact of Environmental Enrichment on Down Syndrome Models

Lecturer: Mara Dierssen, Ph.D.

Affiliation: Genomic Regulation Center, Spain

Date: November 19, 2010

Length: 1:11:32


Mouse Models of Neurodevelopmental Disorders: Behavioral Assays for Translational Drug Discovery

Lecturer: Jacqueline N. Crawley, Ph.D.

Affiliation: National Institute of Mental Health

Date: November 5, 2010

Length: 1:05:48


Making SENSE of Autism Through Peers, Play, and Performance

Lecturer: Blythe Corbett, Ph.D.

Affiliation: UC Davis MIND Institute

Date: June 4, 2010

Length: 1:21:51

Synopsis: Blythe Corbett, Ph.D. discusses her work at the MIND Institute regarding video modeling, cortisol and stress, and a unique therapeutic intervention -- SENSE Theatre -- that allows children with autism to participate with age-matched peers in theatrical musical performance.


El Autismo: Investigaciones receientes y opciones en el tratamiento, Parte 2

Lecturer: Joaquin Fuentes, M.D.

Affiliation: Policlinica Gipuzkoa, San Sebastian, Spain

Date: February 27, 2010

Length: 1:49:39

Synopsis: Joaquín Fuentes, MD de España, ofrece una visión maravillosa del autismo y el autismo de investigación en curso en su totalidad en el idioma español (Parte 2 de 2). Grabado sáb, 27 de febrero 2010. English Translation: Joaquin Fuentes, M.D. from Spain, gives a wonderful overview of autism and current autism research entirely in the Spanish language (Part 2 of 2).


El Autismo: Investigaciones receientes y opciones en el tratamiento, Parte 1

Lecturer: Joaquin Fuentes, M.D.

Affiliation: Policlinica Gipuzkoa, San Sebastian, Spain

Date: February 27, 2010

Length: 1:13:07

Synopsis: Joaquín Fuentes, MD de España, ofrece una visión maravillosa del autismo y el autismo de investigación en curso en su totalidad en el idioma español (Parte 1 de 2). Grabado sáb, 27 de febrero 2010. English Translation: Joaquin Fuentes, M.D. from Spain, gives a wonderful overview of autism and current autism research entirely in the Spanish language (Part 1 of 2).

 


The GAUTENA Program: Where the Welfare State Meets the Community of Persons with Autism

Lecturer: Joaquin Fuentes, M.D.

Affiliation: Policlinica Gipuzkoa, San Sebastian, Spain

Date: February 26, 2010

Length: 1:22:51

Synopsis: Joaquin Fuentes, M.D. discusses the successful GAUTENA program in the Basque Country of Spain for helping persons on the autism spectrum. Please note: this presentation is in English only.


Developing Neurobehavioral Biomarkers for Targeted Treatment in Fragile X from Human and Animal Studies

Lecturers: Robert F. Berman, Ph.D., Susan Rivera, Ph.D., & Tony J. Simon, Ph.D.

Affiliation: UC Davis MIND Institute

Date: January 29, 2010

Length: 1:29:32

Synopsis: An overview of integrated neuroscience research efforts to study Fragile X-associated tremor ataxia (FXTAS). Specifically, the presentation will describe how studies in human FXTAS patients and basic science findings in transgenic mouse models of FXTAS have been integrated so that each informs the other to accelerate the pace of scientific discovery.